Skip to content
Back to resident companies

GiwoTech

Investment areas

  • Applied AI & ML
  • Biotech / Life Sciences
Founders & Leadership
Ashwin Lokapally
Headquarters
Cambridge, MA

Transforming undruggable targets into viable therapeutics.

The Tough Tech problem we are solving

GiwoTech is tackling the challenge that many of the most important biological and materials problems are governed by complex molecular interactions that are too slow, expensive, or difficult to explore experimentally at scale. Instead of relying solely on laboratory trial‑and‑error, GiwoTech is building ways to understand and predict protein structures, protein–protein interactions, and other molecular behaviors from first principles and data, so that researchers can design precision therapeutics and advanced materials far more efficiently.

About our solution

GiwoTech is developing a next‑generation digital twin platform that combines physics‑based simulation with AI and machine learning to model three‑dimensional structures and functions directly from genetic and molecular information. By creating high‑fidelity, atomic‑level simulations for biomedical, plant, and material applications, the platform is designed to let scientists run in silico experiments, identify promising targets and compounds, and shorten the path from hypothesis to validated candidate in drug discovery and beyond.